CD334 (FGFR4) polyclonal, anti-human
€384.00
In stock
SKU
ARP-10-P9193
Quantity: 100 µg
Background:
FGFR4(Fibroblast growth factor receptor 4), also known as CD334, is a protein that in humans is encoded by the FGFR4 gene. It is mapped to 5q35.2. The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. It is overexpressed in gynecological tumor samples, suggesting a role in breast and ovarian tumorigenesis.
Description:
Rabbit IgG polyclonal antibody for Fibroblast growth factor receptor 4 (FGFR4) detection. Tested with WB, IHC-P in Human.
Synonyms:
CD 334 antibody, CD334 antibody, CD334 antigen antibody, fc13h 10 antibody, fc13h10 antibody, Fgfr 4 antibody, FGFR-4 antibody, Fgfr4 antibody, FGFR4_HUMAN antibody, Fibroblast growth factor receptor 4 antibody, Hydroxyaryl protein kinase antibody, JTK 2 antibody, JTK2 antibody, MGC20292 antibody, Protein tyrosine kinase antibody, TKF antibody, Tyrosine kinase related to fibroblast growth factor receptor antibody, Tyrosylprotein kinase antibody
Isotype: Rabbit polyclonal IgG
Immunogen:
E.coli-derived human FGFR4 recombinant protein (Position: L22-H206). Human FGFR4 shares 86% and 84% amino acid (aa) sequences identity with mouse and rat FGFR4, respectively.
Form: Lyophilized; Each vial contains 5mg BSA, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg NaN3.
Specificity:
No cross reactivity with other proteins.
Reactivity: Reacts with: human
Applications: WB, IHC-P
Reconstitution:
Add 0.2ml of distilled water will yield a concentration of 500ug/ml.
Storage: At -20˚C for one year. After reconstitution, at 4˚C for one month. It can also be aliquotted and stored frozen at -20˚C for a longer time. Avoid repeated freezing and thawing.
| Is Featured? | No |
|---|
Write Your Own Review